Trust Company of Vermont’s Array Biopharma Inc ARRY Stock Holding History

Trust Company of Vermont’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-43	Closed	-$2K	–	1071
2019 Q2	$2K	Hold	43	–	–	﹤0.01%	982
2019 Q1	$1K	Buy	+43	New	+$895	﹤0.01%	969

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Trust Company of Vermont's ARRY Position: Q3 2019 in Review

Trust Company of Vermont sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 43 shares — an estimated $2K sold.

Trust Company of Vermont first reported a position in ARRY in Q1 2019 and held it in 2 quarters. The position peaked at $2K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Trust Company of Vermont reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Trust Company of Vermont sold 43 Array Biopharma Inc shares in Q3 2019, an estimated $2K.
Trust Company of Vermont first reported a position in Array Biopharma Inc in Q1 2019 and held it in 2 quarters.
Trust Company of Vermont's Array Biopharma Inc position peaked at $2K in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Trust Company of Vermont's 13F filing for Q3 2019, filed 24 Oct 2019.